MBX Biosciences, Inc. Common Stock (MBX) — Financial statements
Income statement, balance sheet, and cash flow for MBX Biosciences, Inc. Common Stock — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.25 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -0.25 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | |||||
| R&D Expenses | 79↑37.9% | 57↑101.2% | 29↑33.4% | 21 | |
| General & Administrative Expenses | 19↑75.3% | 11↑59.1% | 7↑80.0% | 4 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 19↑75.3% | 11↑59.1% | 7↑80.0% | 4 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 98↑43.8% | 68↑93.1% | 35↑40.3% | 25 | |
| Total Costs & Expenses | 98↑43.8% | 68↑93.1% | 35↑40.3% | 25 | |
| Operating Results | |||||
| Operating Income | -98↓43.8% | -68↓93.1% | -35↓40.3% | -25 | |
| Depreciation & Amortization | 0.25↑1.6% | 0.24↑55.4% | 0.16↑180.4% | 0.06 | |
| EBITDA | -98↓44.3% | -68↓93.3% | -35↓36.8% | -26 | |
| EBIT | -98↓43.8% | -68↓93.1% | -35↓37.1% | -26 | |
| Interest & Other Income | |||||
| Net Interest Income | 11↑76.7% | 6↑128.2% | 3↑137500.0% | -0.00 | |
| Interest Income | 11↑76.7% | 6↑128.2% | 3↑638.7% | 0.37 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.37 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↓100.0% | 0.60 | |
| Other Income / Expenses | 11↑76.7% | 6↑128.2% | 3↑382.1% | -0.97 | |
| Income Before Tax | -87↓40.5% | -62↓90.2% | -33↓24.6% | -26 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -87↓40.5% | -62↓90.2% | -33↓24.6% | -26 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -87↓40.5% | -62↓90.2% | -33↓24.6% | -26 | |
| Bottom-Line Net Income | -87↓40.5% | -62↓90.2% | -33↓24.6% | -26 | |
| EPS (Basic) | -2.38↓28.6% | -1.85↓81.4% | -1.02↓24.4% | -0.82 | |
| EPS (Diluted) | -2.38↓28.6% | -1.85↓81.4% | -1.02↓24.4% | -0.82 | |
| Weighted Average Shares | 37↑9.3% | 33↑4.8% | 32↑0.0% | 32 | |
| Weighted Average Diluted Shares | 37↑9.3% | 33↑4.8% | 32↑0.0% | 32 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.